Acquired Hemophilia Treatment Market Insights, Global Outlook and Forecast 2022-2028
Acquired Hemophilia Treatment Market Insights, Global Outlook and Forecast 2022-2028
The research report on ‘Acquired Hemophilia Treatment Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages.
The latest research study released by Market IntelliX evaluates market size and forecasts of Acquired Hemophilia Treatment in Global, including the following market information:
Global Acquired Hemophilia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Acquired Hemophilia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Traditional Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acquired Hemophilia Treatment include Baxalta, Inc., Baxter Healthcare Corporation, Bristol-Myers Squibb, Genentech, Inc., Novo Nordisk A/S, Ferring B.V. and Sanofi SA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Acquired Hemophilia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Acquired Hemophilia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Acquired Hemophilia Treatment Market Segment Percentages, by Type, 2021 (%)
Traditional Therapy
Advanced Therapy
Global Acquired Hemophilia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Acquired Hemophilia Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Acquired Hemophilia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Acquired Hemophilia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acquired Hemophilia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Acquired Hemophilia Treatment revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Baxalta, Inc.
Baxter Healthcare Corporation
Bristol-Myers Squibb
Genentech, Inc.
Novo Nordisk A/S
Ferring B.V.
Sanofi SA
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Acquired Hemophilia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acquired Hemophilia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acquired Hemophilia Treatment Overall Market Size
2.1 Global Acquired Hemophilia Treatment Market Size: 2021 VS 2028
2.2 Global Acquired Hemophilia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acquired Hemophilia Treatment Players in Global Market
3.2 Top Global Acquired Hemophilia Treatment Companies Ranked by Revenue
3.3 Global Acquired Hemophilia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acquired Hemophilia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Acquired Hemophilia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acquired Hemophilia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acquired Hemophilia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acquired Hemophilia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Acquired Hemophilia Treatment Market Size Markets, 2021 & 2028
4.1.2 Traditional Therapy
4.1.3 Advanced Therapy
4.2 By Type - Global Acquired Hemophilia Treatment Revenue & Forecasts
4.2.1 By Type - Global Acquired Hemophilia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Acquired Hemophilia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acquired Hemophilia Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Acquired Hemophilia Treatment Revenue & Forecasts
5.2.1 By Application - Global Acquired Hemophilia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Acquired Hemophilia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Acquired Hemophilia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Acquired Hemophilia Treatment Revenue & Forecasts
6.2.1 By Region - Global Acquired Hemophilia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Acquired Hemophilia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Acquired Hemophilia Treatment Revenue, 2017-2028
6.3.2 US Acquired Hemophilia Treatment Market Size, 2017-2028
6.3.3 Canada Acquired Hemophilia Treatment Market Size, 2017-2028
6.3.4 Mexico Acquired Hemophilia Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Acquired Hemophilia Treatment Revenue, 2017-2028
6.4.2 Germany Acquired Hemophilia Treatment Market Size, 2017-2028
6.4.3 France Acquired Hemophilia Treatment Market Size, 2017-2028
6.4.4 U.K. Acquired Hemophilia Treatment Market Size, 2017-2028
6.4.5 Italy Acquired Hemophilia Treatment Market Size, 2017-2028
6.4.6 Russia Acquired Hemophilia Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Acquired Hemophilia Treatment Market Size, 2017-2028
6.4.8 Benelux Acquired Hemophilia Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Acquired Hemophilia Treatment Revenue, 2017-2028
6.5.2 China Acquired Hemophilia Treatment Market Size, 2017-2028
6.5.3 Japan Acquired Hemophilia Treatment Market Size, 2017-2028
6.5.4 South Korea Acquired Hemophilia Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Acquired Hemophilia Treatment Market Size, 2017-2028
6.5.6 India Acquired Hemophilia Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Acquired Hemophilia Treatment Revenue, 2017-2028
6.6.2 Brazil Acquired Hemophilia Treatment Market Size, 2017-2028
6.6.3 Argentina Acquired Hemophilia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acquired Hemophilia Treatment Revenue, 2017-2028
6.7.2 Turkey Acquired Hemophilia Treatment Market Size, 2017-2028
6.7.3 Israel Acquired Hemophilia Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Acquired Hemophilia Treatment Market Size, 2017-2028
6.7.5 UAE Acquired Hemophilia Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Baxalta, Inc.
7.1.1 Baxalta, Inc. Corporate Summary
7.1.2 Baxalta, Inc. Business Overview
7.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Major Product Offerings
7.1.4 Baxalta, Inc. Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.1.5 Baxalta, Inc. Key News
7.2 Baxter Healthcare Corporation
7.2.1 Baxter Healthcare Corporation Corporate Summary
7.2.2 Baxter Healthcare Corporation Business Overview
7.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Major Product Offerings
7.2.4 Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.2.5 Baxter Healthcare Corporation Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Key News
7.4 Genentech, Inc.
7.4.1 Genentech, Inc. Corporate Summary
7.4.2 Genentech, Inc. Business Overview
7.4.3 Genentech, Inc. Acquired Hemophilia Treatment Major Product Offerings
7.4.4 Genentech, Inc. Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.4.5 Genentech, Inc. Key News
7.5 Novo Nordisk A/S
7.5.1 Novo Nordisk A/S Corporate Summary
7.5.2 Novo Nordisk A/S Business Overview
7.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Major Product Offerings
7.5.4 Novo Nordisk A/S Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.5.5 Novo Nordisk A/S Key News
7.6 Ferring B.V.
7.6.1 Ferring B.V. Corporate Summary
7.6.2 Ferring B.V. Business Overview
7.6.3 Ferring B.V. Acquired Hemophilia Treatment Major Product Offerings
7.6.4 Ferring B.V. Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.6.5 Ferring B.V. Key News
7.7 Sanofi SA
7.7.1 Sanofi SA Corporate Summary
7.7.2 Sanofi SA Business Overview
7.7.3 Sanofi SA Acquired Hemophilia Treatment Major Product Offerings
7.7.4 Sanofi SA Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
7.7.5 Sanofi SA Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Acquired Hemophilia Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|